ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Innovative Psychedelics Introduces Patient Appointments for Ketamine for Pain Treatment

Downers Grove, IL (Newsworthy.ai) Sunday Jan 21, 2024 @ 7:00 AM Eastern —

Innovative Psychedelics, a leading clinic in mental health treatments, is excited to offer new patient appointments for IV ketamine therapy, targeting severe depression, mood disorders, and chronic pain. Our expert medical team, equipped with the latest technology, delivers personalized care for those seeking relief from chronic pain.

Known for our expertise in depression and ketamine pain therapy, we've also successfully introduced Spravato treatments. We specialize in helping individuals with chronic pain who are unresponsive to traditional treatments or those preparing for surgery. Conditions treated include cancer, CRPS, fibromyalgia, neuropathic pain, phantom pain, postherpetic neuralgia, sickle cell disease, and spinal injuries.

Our pain treatment involves a three-hour infusion, typically once a month. It's important to note that ketamine infusion for mood or pain disorders is off-label and not FDA-approved for this use. Side effects can include high blood pressure, nausea, vomiting, and perceptual disturbances.

Innovative Psychedelics specializes in innovative mental health treatments, with a team of experienced professionals providing personalized care for depression, mood disorders, and chronic pain.

In addition to its Chicago clinic, Innovative Psychedelics has a location in Downers Grove, IL. Visit their website for contact details and hours of operation for both locations.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform.™

The reference URL for this press release is located here Innovative Psychedelics Introduces Patient Appointments for Ketamine for Pain Treatment.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.